← 返回专利悬崖列表

氯那法尼

Tier C · 观察 / 贸易

Lonafarnib

默沙东
原研
2020
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型

靶点:Ftase

商品名:Zokinvy、ZOKINVY

适应症(已批准):早衰综合征

各地区研发/上市状态

美国
批准上市
2020-11-20
欧盟
批准上市
2022-07-18
中国
-
日本
批准上市
2024-01-18

合成路线与中间体3 routes

原研路线 × 1优化路线(非专利)× 2工艺路线 × 0

路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。

原研Route 2步骤 9 · 总收率 5.44 g
LONA-008157688-46-5LONA-009193276-76-5LONA-010193276-77-6LONA-011562883-39-0LONA-012—LONA-013—LONA-014679842-23-0LONA-015679842-25-2LONA-016679842-29-6LONA-017679842-27-4LONA-018272107-22-9LONA-019141699-59-4LONA-020273216-60-7LONA-021—API · 氯那法尼
编号CAS 号中间体名称
LONA-008157688-46-52-(1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid
LONA-009193276-76-5tert-butyl (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxylate
LONA-010193276-77-6(R)-1-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-(piperidin-4-yl)ethan-1-one
LONA-011562883-39-03-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-012-3-bromo-8-chloro-7-nitro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-013-3-bromo-8-chloro-9-nitro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-014679842-23-03-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-7-amine
LONA-015679842-25-23-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-9-amine
LONA-016679842-29-63,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-7-amine
LONA-017679842-27-43,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-9-amine
LONA-018272107-22-93,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-019141699-59-4在售tert-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate
LONA-020273216-60-7tert-butyl (R)-4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidine-1-carboxylate
LONA-021-tert-butyl (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxylate acetyl-L-phenylalaninate
优化Route 1步骤 9 · 总收率 1.4 g
LONA-001165740-12-5LONA-002193276-34-5LONA-003193276-44-7LONA-004193276-45-8LONA-005193276-46-9LONA-006193276-47-0LONA-007193276-49-2LONA-008157688-46-5LONA-009193276-76-5LONA-010193276-77-6API · 氯那法尼
编号CAS 号中间体名称
LONA-001165740-12-5ethyl 4-(3-bromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
LONA-002193276-34-5ethyl 4-(3-bromo-8-chloro-9-nitro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
LONA-003193276-44-7ethyl 4-(9-amino-3-bromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
LONA-004193276-45-8ethyl 4-(9-amino-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
LONA-005193276-46-9ethyl 4-(3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
LONA-006193276-47-03,10-dibromo-8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-007193276-49-2(R)-3,10-dibromo-8-chloro-11-(piperidin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-008157688-46-52-(1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid
LONA-009193276-76-5tert-butyl (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxylate
LONA-010193276-77-6(R)-1-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-(piperidin-4-yl)ethan-1-one
优化Route 3步骤 3 · 总收率 /
LONA-006193276-47-0LONA-007193276-49-2LONA-022102096-25-3LONA-023—LONA-024193276-47-0API · 氯那法尼
编号CAS 号中间体名称
LONA-006193276-47-03,10-dibromo-8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-007193276-49-2(R)-3,10-dibromo-8-chloro-11-(piperidin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
LONA-022102096-25-3在售2,2,2-trifluoroethyl isobutyrate
LONA-023-1-(4-(3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)-2-methylpropan-1-one
LONA-024193276-47-03,10-dibromo-8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine

常见问题(FAQ)

氯那法尼的适应症有哪些?

已批准的适应症包括:早衰综合征。

氯那法尼的专利什么时候到期?

氯那法尼的专利到期年暂无公开口径,本页会在数据管道核实后更新。

氯那法尼有几条合成路线?

本站收录 3 条合成路线,最短路线 3 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。

氯那法尼的关键中间体在哪里可以采购?

氯那法尼的多条路线中间体已挂接 CAS 档案,其中 2 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。

如何获取氯那法尼中间体的报价?

在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。

数据来源:多源数据交叉核实(仅结构化字段) · 2026-10-22